I-MAB (NASDAQ:IMAB) Stock, Quote.Headers.trade-ideas

I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

News

Penny Stocks

Price Target

Markets

Analyst Ratings

Trading Ideas

CSGP

GPOR

IMAB

NVDA

SMAR

TSLA

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

ABBV

Key Takeaways:


	I-Mab has appointed Raj Kannan as its new CEO, filling its top position 18 months after its last top executive quit
	The new CEO is an industry veteran who engineered sales of his previous two companies after bringing their first drugs to market, hinting that I-Mab could follow a similar path


By Warren Yang

I-Mab Gets New CEO After Long Search. Sale Of The Company Coming Next?

Biotech

Short Ideas

General

On Wednesday, shares of I Mab (NASDAQ: IMAB) experienced volatile short activity. After the activity, the stock price went down -1.86% to $3.16.

The overall sentiment for IMAB has been Bearish.

Short Volatility Alert: I Mab

HSBC analyst Carlos Gomez-Lopez upgrades Itau Unibanco Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITUB#NYSE">ITUB</a>) from Hold to Buy and announces $6.8 price target.

Upgrades

ITUB

HSBC Upgrades Itau Unibanco Holding to Buy, Announces $6.8 Price Target

<a href="https://www.benzinga.com/news/25/01/42854907/shaq-explains-why-he-spends-1000-on-pedicures-i-feel-sorry-for-the-young-lady-doing-my-feet">Shaquille O'Neal</a> might be one of the greatest basketball players, but even legends feel the heat. During his rookie season with the Orlando Magic, a rough game against the New York Knicks left him frustrated and doubting himself. His late stepfather, Phillip Harrison, wasn't about to let Shaq wallow. Instead, Harrison delivered one of the most memorable lessons of O'Neal's life – and it wasn't on the court.
After a tough game against the New York Knicks, Shaq was feeling the strain of the NBA. He'd gone up against Patrick Ewing and hadn't performed well. Back at his hotel, his phone rang. "My father says, ‘Get your a&#x2A;&#x2A; home right now. I don't want to talk to you. Be here tomorrow at 0500. If you don't, I'm going to knock your a&#x2A;&#x2A; out,'" Shaq recalled in a video posted to YouTube in June 2024.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
O'Neal took a private plane home and arrived on time the next morning. "I'm there at 5 a.m. and he's already dressed. We get in the car and we ride," he said. Confused, Shaq asked what was going on. "‘Shut the hell up, we're just riding,'" Harrison responded.
Eventually, they encountered a homeless family sitting on the street – a man, his wife and two kids. Harrison stopped the car and the two of them observed silently. After a while, Harrison asked Shaq about the game. "He said, ‘What happened to the game yesterday?' I said, ‘Man, I don't know. I let the pressure get to me.'"
That response didn't sit well with Harrison. "‘You spoiled mother f&#x2A;&#x2A;&#x2A;er, <a href="https://www.benzinga.com/personal-finance/25/01/42818956/nba-legend-shaq-says-he-wont-care-if-he-loses-every-dime-of-his-500-million-net-worth-i-dont-even-work-for-money-i-work-for-fun">making all this money</a>, talking about pressure? This is pressure,'" he told Shaq, pointing to the homeless family. "‘When you don't know where your next meal is coming from.'"
See Also: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
The lesson hit Shaq hard. He exited the car and approached the man to hear his story. "He said, ‘Look man, I just lost my job, I just got down on some hard times.' But he was very dedicated. Like, ‘I'm going to get back, I'm going to get back.'"
Moved by their situation, Shaq decided to act. "I said, ‘Alright, hold on.'" He called a friend and asked, "You still got them apartments that you're building? I need a three-bedroom apartment today. How much? $36,000. I'm going to wire you the money."
But Shaq didn't stop there. After securing a home for the family, he asked the man what kind of work he could do. "I said, ‘What do you like to do?' He said, ‘Man, I'll do whatever.'" Shaq called another friend who ran a lawn service company. "I'm going to send this guy over. Boom boom boom. Make sure he gets paid, whatever. I'll pay you back."
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
The family's <a href="https://www.benzinga.com/24/11/42118033/nba-legend-shaq-put-his-mom-and-dad-on-payroll-when-he-made-it-big-in-basketball-now-you-making-half-a-million-a-year">story came full circle</a> two years later. "Two years after that, the guy started his own lawn service," Shaq said. "He was <a href="https://www.benzinga.com/real-estate/24/10/41168132/nba-legend-shaq-only-used-2-rooms-in-his-76-000-sq-ft-mansion-the-kitchen-because-i-like-to-eat-and">cutting my grass in Orlando</a>."
Reflecting on the experience, Shaq shared how it changed his perspective. "Pressure to me is when you don't know where your next meal is coming from."
This story is one of many that reveal the depth of Shaq's character and the lessons his father imparted. It's a reminder that success isn't just about performance on the court – it's about what you do off it too.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

Personal Finance

NBA Star Shaq Learned 'True Meaning Of Pressure' After His Dad Took Him To A Homeless Family – He Paid $36,000 To Get Them Off The Streets

In the current market session, First Citizens BancShares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) share price is at $2063.99, after a 0.01% increase. Moreover, over the past month, the stock fell by 2.08%, but in the past year, spiked by 49.60%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1736787611_0.png" alt="Past Year Chart" />

<h3>Comparing First Citizens BancShares P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 12.45 in the Banks industry, First Citizens BancShares Inc. has a lower P/E ratio of 11.82. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1736787611_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

FCNCA

Price Over Earnings Overview: First Citizens BancShares

HSBC analyst Christopher Johnen maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and raises the price target from $225 to $270.

AMZN

HSBC Maintains Buy on Amazon.com, Raises Price Target to $270

Legal

Texas Sues Allstate, Accusing It Of Unlawfully Collecting And Selling Data About The Location And Movement Of Texans' Cellphones

WIIM

A.k.a. brands shares are trading higher after the company reported preliminary FY24 and Q4 revenue results.

Needham analyst N. Quinn Bolton noted 2024&#8217;s divergence of the fortunes of <a href="https://www.benzinga.com/topic/semiconductors" target="_blank" rel="noreferrer noopener">semiconductor companies exposed</a> to different end markets. 
Semiconductor suppliers exposed to the PC, smartphone, industrial, and automotive sectors generally noticed fundamentals under pressure throughout the year.
On the other hand, the AI segment experienced strong demand for accelerating deployments of AI infrastructure.
Also Read: <a href="https://www.benzinga.com/government/regulations/25/01/42907937/taiwan-semiconductor-hits-26-3-billion-q4-revenue-reportedly-ends-powerair-deal-over-huawei-chip-breach-amid-us-sanctions" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Hits $26.3 Billion Q4 Revenue, Reportedly Ends PowerAIR Deal Over Huawei Chip Breach Amid US Sanctions</a>
As a result, AI-driven semiconductor stocks significantly outperformed the S&amp;P 500 Index and non-AI-driven semiconductor stocks in 2024.
The performance of AI and non-AI stocks may begin to see some mean reversion, Bolton says. Growth in AI revenue will begin to decelerate and fundamentals for analog/mixed-signal semiconductor companies will start to recover.
Bolton named Allegro MicroSystems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) his top pick for 2025 and added the company to Needham&#8217;s Conviction List.
Bolton noted that 2024 was the year of the &#8220;haves&#8221; and the &#8220;have nots&#8221; in the semiconductor industry. Due to the combination of weak demand conditions and digestion of excess inventory, semiconductor suppliers exposed to the PC, smartphone, industrial, and automotive end markets generally experienced revenue and earnings declines in 2024.
While the S&amp;P 500 Index returned 23% in calendar year 2024, the average return for the &#8220;non-AI&#8221;-driven semiconductor companies in Bolton&#8217;s coverage universe was -17 %.
On the other hand, driven by strong demand for accelerating deployments of AI infrastructure, semiconductor companies with exposure to AI saw robust revenue and earnings growth.
On average, the stock prices of AI-driven companies in Bolton&#8217;s coverage universe increased 147% in 2024, significantly outperforming the 23% return of the S&amp;P 500 over this period.
Bolton noted that broad-based, analog/mixed-signal, and cyclical recovery stocks may outperform in 2025. In 2025, Bolton expects the performance of AI and non-AI stocks to begin to see some mean reversion as growth in AI revenue begins to decelerate and fundamentals for analog/mixed-signal semiconductor companies begin to recover.
Bolton did not call for this rotation from AI names to analog/mixed-signal or other semiconductor cycle plays to necessarily occur in early 2025. The near-term outlook for many analog/mixed-signal stocks remains muted in the near-term while he expects continued momentum in revenue and earnings for the AI-related stocks. However, Bolton noted this rotation could begin in the Spring to early Summer.
AI spending is decelerating, which may lead to multiple contractions.
Potential catalysts for the rotation included the end of inventory digestion and improvements in end market demand. The trend toward autonomy and electrification in autos is intact and should drive semiconductor growth, and valuations that are more compelling than those for AI-driven stocks.
Bolton also remains positive on Silicon Laboratories, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>), Lattice Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>), and ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>).
Bolton noted Silicon Labs as an idiosyncratic semiconductor play that is not dependent on a macro recovery in 2025 as new design win ramps in smart meters in India, electronic shelf labeling and continuous glucose monitors, as well as the ramp of new single-stream WiFi 6 and Bluetooth 6 products, should drive sequential growth through the year. 
Bolton also explained that Lattice Semiconductor is poised for the second half of calendar 2025 recovery as the inventory correction in its Industrial &amp; Automotive segment clears and the company ramps up new Nexus and Avant product offerings. 
Lastly, while ON Semiconductor management expects sub-seasonal results in the first half of calendar 2025, Bolton noted the company is highly leveraged to a cyclical recovery and could see the name perform well in the second half of calendar 2025.
Bolton noted Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) (Buy, $160 price target), Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), and Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) (Buy, $120 price target) will all benefit from the strong unit growth of XPUs, both general purpose GPUs and hyperscaler custom ASICs, over the coming years.
Bolton&#8217;s favorite ways to play the connectivity trend in AI data centers include:
<ul>
<li>Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) — Buy, $140 price target</li>
<li>Credo Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) — Buy, $80 price target</li>
<li>MACOM Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) — Buy, $150 price target</li>
<li>Semtech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) — Buy, $74 price target. </li>
</ul>
Bolton increased his price targets on Astera Labs $100 to $140 and Credo Technology from $70 to $80. 
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42900314/nvidia-teams-up-with-dutch-government-to-build-cutting-edge-ai-supercomputer-facility" target="_blank" rel="noreferrer noopener">Nvidia Teams Up with Dutch Government to Build Cutting-Edge AI Supercomputer Facility</a></li>
</ul>
Image: Shutterstock

Reiteration

Tech

ALAB

ALGM

AVGO

CRDO

LSCC

MRVL

MTSI

SLAB

SMTC

Nvidia, Broadcom, Marvell Positioned For Growth As AI Demand Drives Semiconductor Momentum

JMP Securities analyst Devin Ryan downgrades PJT Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) from Market Outperform to Market Perform.

Downgrades

JMP Securities Downgrades PJT Partners to Market Perform

STIM

Neurtonetics shares are trading higher after the company announced preliminary Q4 and FY24 revenue results.

XXII

22nd Century Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 155.2%

PBPB

Potbelly shares are trading higher after the company reported preliminary Q4 financial results.

Trump Media & Technology Group shares are trading higher. The stock may be gaining ahead of President-elect Donald Trump's inauguration.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Shares of health insurers are trading higher after The Centers for Medicare & Medicaid Services proposed a rise to Medicare Advantage payments.

22nd Century Group Shares Resume Trading

INZY

Inozyme Pharma shares are trading lower after multiple firms cut their respective price targets on the stock.

Shares of California utility companies are trading lower amid wildfires in California.

FDMT

4D Molecular Therapeutics shares are trading lower after Leerink Partners and Morgan Stanley cut their respective price targets on the stock.

22nd Century Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 113.7%

AMWL

American Well shares are trading higher after Wells Fargo upgraded the stock from Equal-Weight to Overweight.

NVRO

Nevro shares are trading higher after the company announced preliminary Q4 and FY24 financial results.

I-Mab Biopharma GAAP EPS of -$0.11 misses by $0.04

I-Mab Adr ( ($IMAB) ) has released its Q3 earnings. Here is a breakdown of the information I-Mab Adr presented to its investors. I-Mab is a U.S.-ba...

I-Mab's Third Quarter Results: Progress in Cancer Immunotherapies

I-MAB (IMAB) has released an update. I-Mab Biopharma has completed its transition to a US-based biotech, focusing its efforts on a streamlined orga...

I-Mab Biopharma's Strategic Shift to US-Based Biotech

I-Mab (IMAB) highlighted its strategic outlook for 2025 and a re-prioritization of resources, with a focus on advancing its lead program, givastomi...

I-Mab announces givastomig as lead program

I-MAB ( ($IMAB) ) has shared an update. I-Mab has announced a strategic portfolio prioritization, focusing on the development of givastomig, a bisp...

I-Mab Prioritizes Givastomig as Lead Program in Strategic Shift

I-Mab stock jumps 15% following pipeline update

An announcement from I-MAB ( ($IMAB) ) is now available. I-Mab announced that Wei Fu, Chairman of the Board, plans to purchase up to $2,000,000 of ...

I-Mab Board Chairman to Acquire $2 Million in ADSs

I-Mab announces open market purchases by board member

Analyst Gil Blum of Needham maintained a Buy rating on I-MAB (IMAB – Research Report), with a price target of $4.00. Gil Blum's rating is based on ...

I-Mab Maintains Buy Rating Amid Strategic Refocus on Givastomig and Financial Stability

I-MAB ( ($IMAB) ) has issued an announcement. I-Mab Biopharma has completed the divestiture of its China operations and is advancing its clinical s...

I-Mab Biopharma Advances Precision Immuno-Oncology Programs Post-China Divestiture

Press Releases

I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer

I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024

I-Mab to Participate at the Truist Securities BioPharma Symposium

I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer

Earnings

I-Mab Reports Third Quarter 2024 Results

I-Mab to Participate at the Piper Sandler Healthcare Conference

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member

Comments

I-MAB

I-MAB (IMAB) Forecast

I-MAB (NASDAQ:IMAB) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga